论文部分内容阅读
目的:探讨欣母沛在治疗产后出血的临床疗效。方法:对所选取的江苏省妇幼保健院2011年3月之前收治的110例由于子宫收缩乏力引起的产后出血患者的资料进行分析,分成观察组(欣母沛治疗组)60例和对照组(常规治疗组)50例,观察两组患者的临床疗效。结果:(1)60例观察组患者中54例患者疗效显著,显效率为90%,5例有效,总有效率为98.33%;50例对照组患者中25例患者疗效显著,显效率为50%,5例有效,总有效率为60%;两组在总有效率方面具有统计学差异(P<0.05)。(2)观察组出现恶心呕吐2例,面部潮红1例,不良反应发生率为5%,但症状均较轻微,多为一过性反应,不需治疗。对照组无明显不良反应发生。结论:欣母沛治疗宫缩乏力性产后出血效果显著,但需注意治疗过程中出现的不良反应。
Objective: To investigate the clinical efficacy of Xin-Pei in the treatment of postpartum hemorrhage. Methods: The data of 110 cases of postpartum hemorrhage caused by uterine atony in March 2011 were collected and analyzed. The data were divided into observation group (Xinmaitai group) 60 cases and control group Conventional treatment group) 50 cases, the clinical efficacy of two groups were observed. Results: (1) Of the 60 patients in the observation group, 54 patients had significant efficacy, with a significant efficiency of 90%, 5 were effective and a total effective rate was 98.33%. Out of 50 patients in the control group, 25 patients were significantly effective and effective rate was 50 %, 5 cases were effective and the total effective rate was 60%. There was a significant difference between the two groups in the total effective rate (P <0.05). (2) In the observation group, nausea and vomiting occurred in 2 cases and facial flushing in 1 case. The incidence of adverse reactions was 5%. However, the symptoms were mild and mostly transient. There was no need for treatment. No significant adverse reactions occurred in the control group. Conclusion: Xinmaopen treatment of uterine inertia significant postpartum hemorrhage, but should pay attention to the adverse reactions occurred during the treatment.